Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by Sonny7on Aug 16, 2012 10:39am
151 Views
Post# 20224332

RE: Today's News

RE: Today's News

I carefully read the news and forward looking statements aside, I see it as strong and positive news with the "meat and potatoes" of it copied below. Necker Hospital shows a high Ievel of confidence in VMS. I like the idea of them campaigning the product in Europe.

 

"We are pleased to start using the VMS at our facility in Necker Hospital," said Damien Bonnet, professor, chief of pediatric cardiology at Necker Hospital. "Access to MRI is limited at our site and VMS allows us to provide better and more efficient patient care." Mr. Bonnet added: "The right ventricular volumes that are obtained from VMS are as accurate as MRI and we feel comfortable making clinical decisions using VMS. VMS is easy to use and quick to acquire and analysis the data."

Yann de Tonquedec, president of Cardio-Systemes, said: "My partner, Dr. Mirochnik, and myself are very excited to start distributing such a great product in France, it fills a market gap and we see good market potential in France." Dr. Mirochnik also works at the echo lab of Hopital Europeen Georges Pompidou.

"We are actively engaging more customers in France and adding a reputable company such as Cardio-Systemes will allow us to grow faster and better serve our customers by having a local presence," said Amol Karnick, vice-president, sales and business development, of Ventripoint. "We continue to grow our European network of reference centres and will be adding more distributors in various European countries."

Bullboard Posts